Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses

Clinical trial NCT01615796 · COMPLETED

Trial details

NCT number: NCT01615796
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Respiratory Tract

Start date: 2012-06-04
Primary completion: 2014-02-21
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.